Follicular Lymphoma, bcl-2/JH t(14;18), FISH
Complement Component C3, Nephritic Factor
Sexually Transmitted Infection (STI) Pathogen Panel, Molecular
Carnitine, Total, Urine
Minimal Residual Disease (MRD) for Early Detection of Cancer Recurrence (Signatera™, Haystack MRD™)
UBE3A Gene Mutation Analysis, Angelman Syndrome, Blood
Hepatitis E Virus (HEV) RNA, Molecular, Quantitative
Uniparental Disomy, FISH, Blood
21-Hydroxylase Antibody
Chromatin Antibody, IgG
LDS
Sign up
Log in
LDS
/
Medical Tests
/
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
ICD10
Additional ICD10
References
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
Medical Test
Clinical Utility
Access to
EarlyTect® Bladder Cancer Detection Test (PENK Gene Methylation Assay)
is restricted.
Sign up now
Loading...